Docosahexaenoic acid prevents peroxisomal and mitochondrial protein loss in a murine hepatic organoid model of severe malnutrition

Biochim Biophys Acta Mol Basis Dis. 2025 Aug;1871(6):167849. doi: 10.1016/j.bbadis.2025.167849. Epub 2025 Apr 29.

Abstract

Introduction: Acute and chronic exposure of cells to low amino acid conditions have been shown to lead to a reduction in hepatic peroxisomal and mitochondrial content. There is limited understanding of the underlying mechanisms behind this loss, but data suggests degradation through autophagy. Both organelles play a key role in fatty acid metabolism, which may explain why dysfunction in either one of them might lead to hepatic steatosis.

Methods: Using a previously established murine hepatic organoid model of severe malnutrition, we characterized the effects of prolonged amino-acid restriction on peroxisomal and mitochondrial protein levels and on autophagic flux. To do so, we developed concatemers of 13C-labelled peptide standards for quantification of over 50 different peroxisomal proteins. To assess the autophagic flux, we transduced hepatic organoids with a GFP-LC3-RFP-LC3ΔG probe. Finally, the effect of PPAR-α activation on peroxisomal loss was determined with various agonists.

Results: Prolonged (96 h) amino-acid restriction led to a more severe loss of peroxisomes than a 48 h restriction, and with a substantial induction of autophagic flux. This was accompanied by accumulation of intracellular triglycerides, loss of mitochondrial and peroxisomal proteins, and loss of peroxisomal functionality. While PPAR-α agonists WY-14643 and linoleic acid (LA) had no effect, docosahexaenoic acid (DHA) supplementation partly prevented peroxisomal and mitochondrial loss under amino-acid restricted conditions and partly inhibited autophagy.

Discussion: The potential of DHA to prevent loss of peroxisomes and mitochondrial functions in low protein diets and severe malnutrition warrants further causal and translational testing in preclinical models and clinical trials, including its use as nutritional supplement.

Keywords: Autophagy; Malnutrition; Organoids; Peroxisomes; Polyunsaturated fatty acids.

MeSH terms

  • Animals
  • Autophagy / drug effects
  • Disease Models, Animal
  • Docosahexaenoic Acids* / pharmacology
  • Liver* / drug effects
  • Liver* / metabolism
  • Liver* / pathology
  • Male
  • Malnutrition* / drug therapy
  • Malnutrition* / metabolism
  • Malnutrition* / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mitochondrial Proteins* / metabolism
  • Organoids* / drug effects
  • Organoids* / metabolism
  • Organoids* / pathology
  • PPAR alpha / agonists
  • PPAR alpha / metabolism
  • Peroxisomes* / drug effects
  • Peroxisomes* / metabolism
  • Peroxisomes* / pathology

Substances

  • Docosahexaenoic Acids
  • Mitochondrial Proteins
  • PPAR alpha